Diphtheria News and Research

RSS
Diphtheria is a disease caused by a bacterium, Corynebacterium diphtheriae, that usually affects the tonsils, throat, nose and/or skin. It is passed from person to person by droplet transmission, usually by breathing in diphtheria bacteria after an infected person has coughed or sneezed. Although diphtheria disease is rare in the U.S., it appears that C diphtheriae continues to circulate in areas of the country with previously endemic diphtheria. Diphtheria also occurs in many other parts of the world.
British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Vaccinations recommended for adults

Vaccinations recommended for adults

Immunizations Across the Lifespan campaign launched to educate adults on current vaccinations

Immunizations Across the Lifespan campaign launched to educate adults on current vaccinations

Immunization campaigns to be launched simultaneously in 112 countries and territories

Immunization campaigns to be launched simultaneously in 112 countries and territories

Merck to market and distribute MBL's Td vaccine in the U.S.

Merck to market and distribute MBL's Td vaccine in the U.S.

New pilot program to boost HPV and Tdap vaccination rates among women

New pilot program to boost HPV and Tdap vaccination rates among women

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

PhRMA report: 234 medicines in development for special health care needs of children

PhRMA report: 234 medicines in development for special health care needs of children

GSK offers free vaccines for low income adults without insurance coverage

GSK offers free vaccines for low income adults without insurance coverage

FDA: Outbreak of campylobacteriosis linked to drinking raw milk

FDA: Outbreak of campylobacteriosis linked to drinking raw milk

Pfizer to supply pneumococcal conjugate vaccines for infants and children

Pfizer to supply pneumococcal conjugate vaccines for infants and children

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

Prevenar 13: Immunogenic and well tolerated in young children previously vaccinated with Prevenar

GAVI calls meeting with existing, potential donors

GAVI calls meeting with existing, potential donors

Supreme Court to hear case on vaccine side effects

Supreme Court to hear case on vaccine side effects

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Researchers develop technology to preserve vaccines in tropical temperatures

Researchers develop technology to preserve vaccines in tropical temperatures

American Red Cross raises $32M in mobile giving for ongoing relief efforts in Haiti

American Red Cross raises $32M in mobile giving for ongoing relief efforts in Haiti

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

New report finds low adult vaccination rates in U.S.

New report finds low adult vaccination rates in U.S.

Despite improvements, aid delivery bottlenecks persist in Haiti

Despite improvements, aid delivery bottlenecks persist in Haiti

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.